JOINT FILING AGREEMENTJoint Filing Agreement • August 23rd, 2013 • Baker Felix • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of the shares of common stock of Xoma Corporation.
AGREEMENTSchedule 13g Agreement • February 14th, 2014 • Baker Felix • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G relating to the Common Stock of Pharmacyclics, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTStatement on Schedule 13g • August 12th, 2013 • Baker Felix • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G relating to the Common Stock of Diadexus, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
JOINT FILING AGREEMENTJoint Filing Agreement • July 23rd, 2012 • Baker Felix • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of the shares of Common Stock of Xoma Corporation.
JOINT FILING AGREEMENTJoint Filing Agreement • July 11th, 2013 • Baker Felix • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of the shares of common stock of Xoma Corporation.
AGREEMENTStatement on Schedule 13g • August 12th, 2013 • Baker Felix • Surgical & medical instruments & apparatus
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G relating to the Common Stock of Derma Sciences, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTAgreement • August 12th, 2013 • Baker Felix • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G relating to the Common Stock of Pharmacyclics, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
JOINT FILING AGREEMENTJoint Filing Agreement • July 13th, 2012 • Baker Felix • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of the shares of Common Stock of Xoma Corporation.
JOINT FILING AGREEMENTJoint Filing Agreement • April 23rd, 2012 • Baker Felix • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of the shares of Common Stock of Xoma Corporation.
AGREEMENTAgreement • April 10th, 2014 • Baker Felix • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G relating to the Common Stock of Diadexus, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTStatement on Schedule 13g • August 12th, 2013 • Baker Felix • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G relating to the Common Stock of ViroPharma Incorporated is being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTAgreement • February 14th, 2014 • Baker Felix • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G relating to the Common Stock of Diadexus, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
AGREEMENTStatement on Schedule 13g • February 14th, 2014 • Baker Felix • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G relating to the Common Stock of ViroPharma Incorporated is being filed with the Securities and Exchange Commission on behalf of each of them.
JOINT FILING AGREEMENTJoint Filing Agreement • November 1st, 2012 • Baker Felix • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of the shares of common stock of Xoma Corporation.
AGREEMENTStatement on Schedule 13g • February 14th, 2014 • Baker Felix • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G relating to the Common Stock of Threshold Pharmaceuticals, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
